Surya P Bhatt1, Ella A Kazerooni2, John D Newell3, John E Hokanson4, Matthew J Budoff5, Chandra A Dass6, Carlos H Martinez7, Sandeep Bodduluri8, Francine L Jacobson9, Andrew Yen10, Mark T Dransfield11, Carl Fuhrman12, Hrudaya Nath13. 1. Division of Pulmonary, Allergy and Critical Care Medicine, University of Alabama at Birmingham, Birmingham, AL; UAB Lung Health Center, University of Alabama at Birmingham, Birmingham, AL; UAB Lung Imaging Core, University of Alabama at Birmingham, Birmingham, AL. Electronic address: sbhatt@uabmc.edu. 2. Department of Radiology, University of Michigan, Ann Arbor, MI. 3. Department of Radiology, University of Iowa, Iowa City, IA. 4. Department of Epidemiology, University of Colorado Anschutz Medical Campus, Aurora, CO. 5. Los Angeles Biomedical Research Institute at Harbor-UCLA Medical Center, Torrance, CA. 6. Department of Radiology, Temple University Hospital, Philadelphia, PA. 7. Division of Pulmonary and Critical Care Medicine, University of Michigan, Ann Arbor, MI. 8. Division of Pulmonary, Allergy and Critical Care Medicine, University of Alabama at Birmingham, Birmingham, AL; UAB Lung Health Center, University of Alabama at Birmingham, Birmingham, AL; UAB Lung Imaging Core, University of Alabama at Birmingham, Birmingham, AL. 9. Department of Radiology, Brigham and Women's Hospital, Boston, MA. 10. Department of Radiology, University of California at San Diego, San Diego, CA. 11. Division of Pulmonary, Allergy and Critical Care Medicine, University of Alabama at Birmingham, Birmingham, AL; UAB Lung Health Center, University of Alabama at Birmingham, Birmingham, AL; UAB Lung Imaging Core, University of Alabama at Birmingham, Birmingham, AL; Birmingham VA Medical Center, Birmingham, AL. 12. Department of Radiology, University of Pittsburgh Medical Center, Pittsburgh, PA. 13. UAB Lung Imaging Core, University of Alabama at Birmingham, Birmingham, AL; Department of Radiology, University of Alabama at Birmingham, Birmingham, AL.
Abstract
BACKGROUND: COPD is associated with cardiovascular disease (CVD), and coronary artery calcification (CAC) provides additional prognostic information. With increasing use of nongated CT scans in clinical practice, this study hypothesized that the visual Weston CAC score would perform as well as the Agatston score in predicting prevalent and incident coronary artery disease (CAD) and CVD in COPD. METHODS: CAC was measured by using Agatston and Weston scores on baseline CT scans in 1,875 current and former smokers enrolled in the Genetic Epidemiology of COPD (COPDGene) study. Baseline cardiovascular disease and incident cardiac events on longitudinal follow-up were recorded. Accuracy of the CAC scores was measured by using receiver-operating characteristic analysis, and Cox proportional hazards analyses were used to estimate the risk of incident cardiac events. RESULTS: CAD was reported by 133 (7.1%) subjects at baseline. A total of 413 (22.0%) and 241 (12.9%) patients had significant CAC according to the Weston (≥ 7) and Agatston (≥ 400) scores, respectively; the two methods were significantly correlated (r = 0.84; P < .001). Over 5 years of follow-up, 127 patients (6.8%) developed incident CVD. For predicting prevalent CAD, c-indices for the Weston and Agatston scores were 0.78 and 0.74 and for predicting incident CVD, they were 0.62 and 0.61. After adjustment for age, race, sex, smoking pack-years, FEV1, percent emphysema, and CT scanner type, a Weston score ≥ 7 was associated with time to first acute coronary event (hazard ratio, 2.16 [95% CI, 1.32 to 3.53]; P = .002), but a Agatston score ≥ 400 was not (hazard ratio, 1.75 [95% CI, 0.99-3.09]; P = .053). CONCLUSIONS: A simple visual score for CAC performed well in predicting incident CAD in smokers with and without COPD. TRIAL REGISTRY: ClinicalTrials.gov; No.: NCT00608764; URL: www.clinicaltrials.gov.
BACKGROUND: COPD is associated with cardiovascular disease (CVD), and coronary artery calcification (CAC) provides additional prognostic information. With increasing use of nongated CT scans in clinical practice, this study hypothesized that the visual Weston CAC score would perform as well as the Agatston score in predicting prevalent and incident coronary artery disease (CAD) and CVD in COPD. METHODS: CAC was measured by using Agatston and Weston scores on baseline CT scans in 1,875 current and former smokers enrolled in the Genetic Epidemiology of COPD (COPDGene) study. Baseline cardiovascular disease and incident cardiac events on longitudinal follow-up were recorded. Accuracy of the CAC scores was measured by using receiver-operating characteristic analysis, and Cox proportional hazards analyses were used to estimate the risk of incident cardiac events. RESULTS: CAD was reported by 133 (7.1%) subjects at baseline. A total of 413 (22.0%) and 241 (12.9%) patients had significant CAC according to the Weston (≥ 7) and Agatston (≥ 400) scores, respectively; the two methods were significantly correlated (r = 0.84; P < .001). Over 5 years of follow-up, 127 patients (6.8%) developed incident CVD. For predicting prevalent CAD, c-indices for the Weston and Agatston scores were 0.78 and 0.74 and for predicting incident CVD, they were 0.62 and 0.61. After adjustment for age, race, sex, smoking pack-years, FEV1, percent emphysema, and CT scanner type, a Weston score ≥ 7 was associated with time to first acute coronary event (hazard ratio, 2.16 [95% CI, 1.32 to 3.53]; P = .002), but a Agatston score ≥ 400 was not (hazard ratio, 1.75 [95% CI, 0.99-3.09]; P = .053). CONCLUSIONS: A simple visual score for CAC performed well in predicting incident CAD in smokers with and without COPD. TRIAL REGISTRY: ClinicalTrials.gov; No.: NCT00608764; URL: www.clinicaltrials.gov.
Authors: Caroline Chiles; Fenghai Duan; Gregory W Gladish; James G Ravenel; Scott G Baginski; Bradley S Snyder; Sarah DeMello; Stephanie S Desjardins; Reginald F Munden Journal: Radiology Date: 2015-03-09 Impact factor: 11.105
Authors: Jan M Hughes-Austin; Arturo Dominguez; Matthew A Allison; Christina L Wassel; Dena E Rifkin; Cindy G Morgan; Michael R Daniels; Umaira Ikram; Jessica B Knox; C Michael Wright; Michael H Criqui; Joachim H Ix Journal: JACC Cardiovasc Imaging Date: 2016-01-06
Authors: Michelle C Williams; John T Murchison; Lisa D Edwards; Alvar Agustí; Per Bakke; Peter M A Calverley; Bartolome Celli; Harvey O Coxson; Courtney Crim; David A Lomas; Bruce E Miller; Steve Rennard; Edwin K Silverman; Ruth Tal-Singer; Jørgen Vestbo; Emiel Wouters; Julie C Yates; Edwin J R van Beek; David E Newby; William MacNee Journal: Thorax Date: 2014-01-28 Impact factor: 9.139
Authors: Divay Chandra; Aman Gupta; Gregory L Kinney; Carl R Fuhrman; Joseph K Leader; Alejandro A Diaz; Jessica Bon; R Graham Barr; George Washko; Matthew Budoff; John Hokanson; Frank C Sciurba Journal: Chest Date: 2021-05-08 Impact factor: 10.262
Authors: Carolina M Perdomo; Ana Ezponda; Jorge M Núñez-Córdoba; José I Herrero; Gorka Bastarrika; Gema Frühbeck; Javier Escalada Journal: Sci Rep Date: 2022-04-21 Impact factor: 4.996
Authors: Paul Leong; Martin I MacDonald; Paul T King; Christian R Osadnik; Brian S Ko; Shane A Landry; Kais Hamza; Ahilan Kugenasan; John M Troupis; Philip G Bardin Journal: ERJ Open Res Date: 2021-02-08
Authors: Lu Chen; Andrey Vavrenyuk; Jun Hong Ren; Pankil Desai; Joseph Bahgat; Michael A Bernstein; Michael I Ebright; Mamatha Gowda; Suzanne Rose; Arzhang Fallahi; Brian Stainken; David H Hsi Journal: Front Cardiovasc Med Date: 2021-06-16